Novartis signals beyond the news: 52+ signals from 7 sources
The latest Novartis signal on this page is from Oct 27, 2026 (Patents): "NOVARTIS AG's patent output is accelerating: 76 grants in the past year, 8 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and Patents (11).
PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn
Get Novartis' live signals in Claude or ChatGPT, or by API
What changed at Novartis this week? Use Autobound signals for novartis.com.- Signals
- 52+
- Sources
- 7
- Last 90 days
- 41
- Latest
- Oct 27, 2026
Source: Autobound Signal API · 77 signals tracked for Novartis · updated
Other signals · latest 10
Latest Novartis signals by source
52+ signals for Novartis across 7 sources.
Patents · Patent pace
NOVARTIS AG's patent output is accelerating: 76 grants in the past year, 8 in the past 30 days.
Over the past year NOVARTIS AG received 76 US patent grants, concentrated in networking / data transmission and health tech / medical informatics; the recent pace (16 in 90 days) is accelerating versus its trailing baseline.
- Grants, 12 months
- 76
- Grants, 90 days
- 16
- Grants, 30 days
- 8
- Pace
- Accelerating
Patents · Patent grant
Novartis was granted a patent for compounds targeting coronavirus diseases.
In October 2026 Novartis patented drug candidates and formulations for treating, managing, or preventing coronavirus-related diseases in clinical and patient-care settings.
- Patent title
- Compounds and compositions for the treatment of coronaviral related diseases
- Grant date
- Oct 27, 2026
- Inventors
- Denghui Bao, Fengfeng Guo, Matthew James Hesse, Viktor Hornak
Web traffic · Traffic snapshot
novartis.com received 1M monthly visits with traffic from 5 countries.
Emerging AI traffic at 1.2% (~14,342 visits). Top: chatgpt.com (85%), gemini.google.com (8%), claude.ai (5%), perplexity.ai (0%).
- Monthly visits
- 1,153,193
- Month over month
- +12.9%
- 3-month change
- -12.6%
- Global rank
- 49,234
Glassdoor · Cross functional collaboration issues
Novartis has bureaucracy and disconnected efforts hampering collaboration
Employees describe massive company bureaucracy and scattered efforts across the organization, with a lack of clarity on roles due to constant shifting of groups.
- Overall rating
- 4.0 of 5
- CEO approval
- 87%
- Reviews read
- 10
- Review window
- Oct 1, 2026 to Oct 9, 2026
Glassdoor · Compensation dissatisfaction
Customer service reps report low pay despite high responsibility
One customer service representative review states there is way too much responsibility for low pay and suggests spreading work out and updating training.
- Overall rating
- 4.0 of 5
- CEO approval
- 87%
- Reviews read
- 10
- Review window
- Oct 1, 2026 to Oct 9, 2026
Reddit · Customer feedback
Novartis is criticized by clinical research professionals for being bureaucratic and having clunky systems.
Post: "Sponsor & FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 40
- Comments
- 16
- Sentiment
- Negative
Website changes · Funding news
Novartis added prominent coverage of its second-quarter and first-half 2026 financial results.
Added homepage feature: “Novartis Financial Results – Q2 2026” and “Novartis announces the company’s financial results for the second quarter and first half of 2026,” with a link to the Q2 2026 results page.
- Page
- /
Web traffic · Traffic decline
novartis.com traffic declined 28% to 1M monthly visits.
Minimal AI traffic at 0.8% (~10,201 visits). Top: chatgpt.com (73%), gemini.google.com (2%), claude.ai (0%).
- Monthly visits
- 1,319,655
- Month over month
- -28.5%
- 3-month change
- +34.4%
- Global rank
- 43,408
Employee growth · Several teams growing
Rapid growth across 15 departments with Education leading at 44% YoY growth.
Company is experiencing multi-department expansion, with 15 departments showing significant growth (≥5% YoY). The fastest growing department is Education at 44% growth, adding approximately 451 employees.
- Total headcount
- 74,718
- Company growth, 1 year
- +7%
- Median tenure
- 6.1 years
LinkedIn
Celebrating our environmental progress!
Celebrating our environmental progress! We are proud to be recognized by CDP, an independent non-profit organization enabling environmental disclosures, with double A list status for the fourth consecutive year – achieving the highest possible ‘A’ rating for our work in both climate and water. This recognition...
- Likes
- 402
- Comments
- 23
- Tags
- Sustainability, Corporate Strategy
Showing 10 of 52+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Novartis with the Signal API
One POST /v1/companies/enrich call with novartis.com returns Novartis signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "novartis.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Novartis other signals
What signals does Autobound track for Novartis besides news and filings?
What are people saying about Novartis online?
What do employees say about working at Novartis?
Has Novartis been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .